CE Unterberg Cuts Ultralife Batteries's Estimates

Analyst James McIlree says the battery manufacturer's outlook remains strong in both military and commercial markets

CE Unterberg cuts Ultralife Batteries (ULBI ) estimates, but reiterates buy.

Analyst James McIlree says he would be a buyer on any weakness resulting from today's reduced revenue guidance from the company, which came after the U.S. Defense Department delayed a purchase.

He thinks the company's 2006 outlook remains strong in both military and commercial markets. He says his buy rating and $18 target reflect 2006 including deliveries on U.S. Army's NextGenII Phase IV award, continued growth in commercial endeavors -- both of which he believes likely.

McIlree cuts his second-quarter revenue estimate by $7 million to $20.7 million and now sees the company breaking even, vs. his former 10 cents earnings per share estimate. He also cuts his 38 cents 2005 earnings per share to 29 cents.

Before it's here, it's on the Bloomberg Terminal.